Journal Home
Search for

Volume 35, Issue 2, Pages 226-231 (February 2006)


View previous. 22 of 25 View next.

Congenital cytomegalovirus (CMV) infection and hearing deficit

Karen B. FowleraCorresponding Author Informationemail address, Suresh B. Boppanab

Received 23 June 2005; received in revised form 14 September 2005; accepted 15 September 2005. published online 29 December 2005.

Abstract 

Background

The association between congenital cytomegalovirus (CMV) infection and sensorineural hearing loss (SNHL) was first described in 1964. Studies over the past four decades have further described the relationship between congenital CMV infection and SNHL in children.

Objectives

This manuscript will review the current knowledge of CMV-related SNHL and summarize the studies completed at the University of Alabama at Birmingham (UAB).

Study Design

A review of the series of studies at UAB that has led to a more detailed characterization of hearing loss due to congenital CMV infection.

Results

Approximately, 22%–65% of symptomatic and 6%–23% of asymptomatic children will have hearing loss following congenital CMV infection. CMV-related SNHL may be present at birth or occur later in childhood. Variability in the severity of CMV-related hearing loss ranges from unilateral high frequency losses to profound bilateral losses.

Conclusions

Congenital CMV infection significantly contributes to SNHL in many infant populations. Although, most children with congenital CMV infection do not develop hearing loss, it is difficult to predict which children with congenital CMV infection will develop hearing loss and, among those who do develop loss, whether or not the loss will continue to deteriorate.

a Departments of Pediatrics, Epidemiology and Maternal and Child Health, University of Alabama at Birmingham, USA

b Departments of Pediatrics and Microbiology, University of Alabama at Birmingham, USA

Corresponding Author InformationCorresponding author at: Department of Pediatrics, 1600 7th Ave So CHB 306, Birmingham, AL 35233-1711, USA. Tel.: +1 205 996 7791; fax: +1 205 975 3221.

PII: S1386-6532(05)00306-9

doi:10.1016/j.jcv.2005.09.016


View previous. 22 of 25 View next.